Hsp90 inhibition: Elimination of shock and stress
Authors:
- Brian S.J. BlaggBBBrian S.J. Blagg
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (17) , 4983-4987
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Impact of Heat-Shock Protein 90 on Cancer MetastasisFuture Oncology, 2009
- DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial InhibitionChemical Reviews, 2009
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009
- Hydrating for Resistance to RadicicolACS Chemical Biology, 2009
- Discovery and development of heat shock protein 90 inhibitorsBioorganic & Medicinal Chemistry, 2009
- P-Glycoprotein–Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock ResponseCancer Research, 2008
- Targeting Hsp90: small-molecule inhibitors and their clinical developmentCurrent Opinion in Pharmacology, 2008
- p23/Sba1p Protects against Hsp90 Inhibitors Independently of Its Intrinsic Chaperone ActivityMolecular and Cellular Biology, 2008
- The Hallmarks of CancerCell, 2000
- The future of antihormone therapy: innovations based on an established principleJournal of Cancer Research and Clinical Oncology, 1996